Stefan Anker
18Patents
3h-index
9Co-inventors
53Inventor score
Filing activity: Oct 15, 1999 → Feb 22, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7417038B1 | Methods of treating cachexia | Human Necessities | 15 | Expired |
| US8252544B2 | Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients | Physics | 12 | Active |
| US8647830B2 | Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease | Physics | 5 | Active |
| US10016397B2 | Selective AT2 receptor agonists for use in treatment of cachexia | Chemistry; Metallurgy | 2 | Active |
| US8835485B2 | Prevention and treatment of sarcopenia | Human Necessities | 1 | Active |
| US10828270B2 | Oxprenolol compositions for treating cancer | Human Necessities | 1 | Active |
| US10398658B2 | Oxprenolol compositions for treating cancer | Human Necessities | 1 | Active |
| US11007158B2 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Human Necessities | 0 | Active |
| US11382876B2 | S-enantiomerically enriched compositions of beta blockers for treating muscle weakness | Human Necessities | 0 | Active |
| US8483824B2 | Method for enhancing the performance and general condition of a subject | Human Necessities | 0 | Active |
| US12303474B2 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Human Necessities | 0 | Active |
| US8383612B2 | Use of megestrol acetate for improving heart function and the treatment of heart insufficiency | Human Necessities | 0 | Active |
| US10449166B2 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Human Necessities | 0 | Active |
| US11096908B2 | S-enantiomerically enriched compositions of beta blockers for treating muscle weakness | Human Necessities | 0 | Active |
| US7829596B2 | Methods of treatment | Human Necessities | 0 | Active |
| US11938102B2 | S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis | Human Necessities | 0 | Active |
| US8655445B2 | Method for enhancing the performance and general condition of a subject | Human Necessities | 0 | Active |
| US11433036B2 | Oxprenolol compositions for treating cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.